CLINICAL_TRIALS
trial_result
· 2012-09-06
Clinical Trial Update: A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler [Phase 1]
Summary
Phase 1 scintigraphy study evaluating nasal deposition of ciclesonide using a novel nasal metered-dose inhaler in allergic rhinitis patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Allergic Rhinitis (AR) | Phase 1 | Status: COMPLETED | Results posted: 2012-09-06